PER-015-98已完成未知
INEZOLID VS. CLARITHROMYCIN IN THE TREATMENT OF UNCOMPLICATED INFECTIONS OF SKIN AND SOFT FABRICS
PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,0 个研究点目标入组 0 人开始时间: 1998年6月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
INEZOLID VS VANCOMYCIN IN THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS DUE TO PRESUMED OR PROVEN TO A GRAM POSITIVE GERM RESISTANT TO METICILLI-A499 Bacterial infection, unspecifiedBacterial infection, unspecifiedA499PER-073-01PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,
进行中（未招募）
不适用
INEZOLID VS VANCOMYCIN/CEFAZOLIN IN THE TREATMENT OF HEMODIALYSIS PATIENTS WITH CATHETER-RELATED GRAM-POSITIVE BLOODSTREAM INFECTIONS.EUCTR2004-005159-32-ITPHARMACIA UPJOH
进行中（未招募）
不适用
inezolid vs Vancomycin/Cefazolin in the treatment of hemodialysis patients with catheter-related gram-positive bloodstream infections - N/AEUCTR2004-005159-32-DEPfizer Pharma GmbH332
进行中（未招募）
1 期
inezolid vs Vancomycin/Cefazolin in the treatment of hemodialysis patients with catheter-related gram-positive bloodstream infections - N/ACatheter-related Gram-positive bloodstream infections.MedDRA version: 7.1Level: LLTClassification code 10007810EUCTR2004-005159-32-SKPfizer Limited322
进行中（未招募）
1 期
inezolid vs Vancomycin/Cefazolin in the treatment of hemodialysis patients with catheter-related gram-positive bloodstream infections - N/AEUCTR2004-005159-32-ESPfizer, S.A332